Instagram Ern-EyeFacebook Ern-EyeTwitter Ern-EyeLinkedIn Ern-EyeYouTube Ern-EyeHow to use the speech recognition tool?
CURETINA
CURETINA
CURETINA personalized medicine in hereditary retinal degenerations
Type: Observational
Status of the trial: Completed
Orphan Drug Recognition: NA
Inclusion
- Opening Date: 0000-00-00
- Closing Date: 2018-06-30
Criteria
Inclusion: Retinal degeneration caused by mutations in either of the genes CRB1, CRX, PROM1
Exclusion: Additional mutations in genes known for causing hereditary retinal degenerations; additional eye diseases influencing the retinal morphology and function (glaucoma, retinal detachment, etc.)
Children: Yes
Adults: Yes
Funder Type: national institution
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
Workgroups
Retinal Rare Eye Diseases (WG1)
This ERN is supported by:
